Consolidated Statements of Operations - USD ($) $ in Millions |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
||||
| Total revenues | $ 77,794 | $ 66,608 | $ 62,286 | |||
| Total costs and expenses | (70,070) | (63,078) | (59,237) | |||
| Gross profit | 7,724 | 3,530 | 3,049 | | ||
| Income/(loss) from operating investments, net | 46 | (16) | 210 | | ||
| General and administrative expense | (5,168) | (4,187) | (4,157) | | ||
| Research and development expense, net | (3,377) | (2,852) | (2,249) | | ||
| Gain on dispositions, net | 2 | 6 | 277 | | | |
| Total Operating Expenses | -8497.0 | -7049.0 | -5919.0 | 0 | 0 | |
| Loss from operations | (773) | (3,519) | (2,870) | | ||
| Other income, net | 1,227 | 1,058 | 551 | | ||
| Total Other Income Expenses | -1232.0 | -1503.0 | -2163.0 | 0 | 0 | |
| Interest and debt expense | (2,459) | (2,561) | (2,714) | | | |
| Loss before income taxes | (2,005) | (5,022) | (5,033) | | ||
| Income tax (expense)/benefit | (237) | (31) | 743 | | ||
| Net loss | (2,242) | (5,053) | (4,290) | | ||
| Less: net loss attributable to noncontrolling interest | (20) | (118) | (88) | |||
| Net loss attributable to Boeing Shareholders | $ (2,222) | $ (4,935) | $ (4,202) | |||
| Basic loss per share (in dollars per share) | $ (3.67) | $ (8.30) | $ (7.15) | |||
| Diluted loss per share (in dollars per share) | $ (3.67) | $ (8.30) | $ (7.15) | |||
| Sales of products | ||||||
| Total revenues | $ 65,581 | $ 55,893 | $ 51,386 | |||
| Cost of goods and services sold | (59,864) | (53,969) | (49,954) | |||
| Sales of services | ||||||
| Total revenues | 12,213 | 10,715 | 10,900 | |||
| Cost of goods and services sold | $ (10,206) | $ (9,109) | $ (9,283) | |||
| X | ||||||||||
- Definition This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures). No definition available.
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Interest and debt related expenses associated with nonoperating financing activities of the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|